Cost-effectiveness modelling of percutaneous coronary interventions in stable coronary artery disease

doi:10.4330/wjc.v7.i10.594

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 7, Issue 10

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6912)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-3) series.

Item

Count

PDF

363

WORD

401

HTML

2961

Figures (1-3)

395

Tables (1-3)

243

Sum=4363

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1030

Download

1519

Sum=2549

Oct 26, 2015 (publication date) through Aug 24, 2024

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Cardiology

ISSN

1949-8462

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Frontier

World J Cardiol. Oct 26, 2015; 7(10): 594-602
Published online Oct 26, 2015. doi: 10.4330/wjc.v7.i10.594

Open in New Tab Full Size Figure Download Figure

Figure 1 General architecture of the bare metal stent (A) and drug eluting stents (B) sequential model. DES: Drug eluting stents; BMS: Bare metal stent; PCI: Percutaneous coronary interventions; CABG: Coronary artery bypass graft; CBA: Coronary balloon angioplasty.

Open in New Tab Full Size Figure Download Figure

Figure 2 Cost distribution shape of the bare metal stent strategy (X axis: % success rate; Y axis: Occurrence probability).

Open in New Tab Full Size Figure Download Figure

Figure 3 Cost distribution shape of the drug eluting stents strategy (X axis: % success rate; Y axis: Occurrence probability).

Citation: Beresniak A, Caruba T, Sabatier B, Juillière Y, Dubourg O, Danchin N. Cost-effectiveness modelling of percutaneous coronary interventions in stable coronary artery disease. World J Cardiol 2015; 7(10): 594-602
URL: https://www.wjgnet.com/1949-8462/full/v7/i10/594.htm
DOI: https://dx.doi.org/10.4330/wjc.v7.i10.594